<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107990/" ref="ordinalpos=3950&amp;ncbi_uid=3003197&amp;link_uid=PMC3107990" image-link="/pmc/articles/PMC3107990/figure/F3/" class="imagepopup">Figure 3. Srcasm may negatively regulate tyrosine kinase <span class="highlight" style="background-color:">signaling</span> in human esophageal squamous cell carcinoma.  From: Decreased Srcasm expression in esophageal squamous cell arcinoma in a Chinese population. </a></div><br /><div class="p4l_captionBody">Srcasm is a component of the EGFR and SFK signaling pathway, and act as a negative regulator of both molecules 9, 12. Our data show that Srcasm protein levels are decreased in esophageal SCC compared to esophageal mucosa. We hypothesize that decreased Srcasm levels promote increased EGFR and SFK activity.</div></div>